A Critical Review of Alcohol Administration Guidelines in Laboratory Medication Screening Research: Is It Time to Include Treatment Seekers?
Alcohol Administration
Alcohol Use Disorder
Human Laboratory
Pharmacotherapy Development
Research Ethics
Journal
Alcoholism, clinical and experimental research
ISSN: 1530-0277
Titre abrégé: Alcohol Clin Exp Res
Pays: England
ID NLM: 7707242
Informations de publication
Date de publication:
01 2021
01 2021
Historique:
received:
14
09
2020
revised:
28
10
2020
accepted:
06
11
2020
pubmed:
16
11
2020
medline:
16
10
2021
entrez:
15
11
2020
Statut:
ppublish
Résumé
Human laboratory studies play an important role in alcohol use disorder (AUD) medication development. Medications that are found to be safe and effective during human laboratory screening will then move to more expensive clinical trials in patient populations. Given the gatekeeping role of human laboratory studies in the medication development pipeline, it is critical that these studies accurately forecast how pharmacotherapies will perform under true-to-life clinical conditions. On the other hand, the design of these studies also must adhere to ethical guidelines: certain aspects of clinical reality cannot be incorporated into screening studies because doing so might place the participant at risk for harm or breach other ethical guidelines. Conventions exist that guide the resolution of these conflicting ideals. This article considers the practice of recruiting non-treatment-seeking heavy drinkers to participate in laboratory screening studies. By convention, volunteers are excluded from laboratory screening studies that involve alcohol administration if they are deemed "treatment seeking," meaning that they recently stopped drinking or are motivated to do so. Although this common practice may reduce risk to participants, findings may not accurately predict medication effects on treatment seekers. Indeed, there is empirical evidence that treatment seekers differ from nontreatment seekers in their responses to medications (Neuropsychopharmacology 2017a; 42: 1776; Am J Drug Alcohol Abuse 2017b; 43: 703; J Psychiatr Res 2006; 40: 383). Here, we argue for the importance of recruiting treatment seekers for this research due to their qualitative difference from nontreatment seekers. We argue that these individuals should be the default population in human laboratory medication screening studies. We conclude by discussing 2 case examples of medication experiments led by our research groups that involved administering medications to treatment seekers.
Identifiants
pubmed: 33190310
doi: 10.1111/acer.14514
pmc: PMC7855436
mid: NIHMS1646500
doi:
Substances chimiques
Adrenergic alpha-2 Receptor Agonists
0
Alcohol Deterrents
0
Guanfacine
30OMY4G3MK
Naltrexone
5S6W795CQM
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
15-24Subventions
Organisme : Intramural NIH HHS
ID : Z01 AA000466
Pays : United States
Organisme : Office of Research on Women's Health
ID : AA027989
Pays : International
Organisme : NIAAA NIH HHS
ID : P01 AA027473
Pays : United States
Organisme : NIAAA NIH HHS
ID : U54 AA027989
Pays : United States
Organisme : NIAAA NIH HHS
ID : AA026890
Pays : United States
Organisme : NIAAA NIH HHS
ID : Z1A000466
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Organisme : NIAAA NIH HHS
ID : K23 AA026890
Pays : United States
Organisme : NIAAA NIH HHS
ID : AA025670
Pays : United States
Organisme : NIAAA NIH HHS
ID : K01 AA025670
Pays : United States
Informations de copyright
© 2020 by the Research Society on Alcoholism.
Références
Am J Drug Alcohol Abuse. 2017 Nov;43(6):703-710
pubmed: 28426264
Addict Biol. 2020 Apr 14;:e12903
pubmed: 32286721
N Engl J Med. 2015 Sep 24;373(13):1192-3
pubmed: 26398069
JAMA Psychiatry. 2019 Apr 1;76(4):374-381
pubmed: 30865232
Bioethics. 2006 Feb;20(1):1-15
pubmed: 16680876
Psychopharmacology (Berl). 2009 Jul;205(1):53-62
pubmed: 19319508
Neuropsychopharmacology. 2006 Jun;31(6):1310-7
pubmed: 16237394
Br J Addict. 1988 Dec;83(12):1429-37
pubmed: 3233410
Drug Alcohol Depend. 2012 Jan 1;120(1-3):162-7
pubmed: 21840650
J Psychiatr Res. 2006 Aug;40(5):383-93
pubmed: 16546214
J Subst Abuse Treat. 2002 Dec;23(4):285-95
pubmed: 12495790
Int J Neuropsychopharmacol. 2015 Jul 25;18(12):
pubmed: 26209857
Biol Psychiatry. 2009 Jul 15;66(2):185-90
pubmed: 19249750
Lancet Psychiatry. 2017 Jun;4(6):469-476
pubmed: 28456501
Biol Psychiatry. 2001 Mar 15;49(6):553-5
pubmed: 11257241
Alcohol Clin Exp Res. 2012 May;36(5):906-14
pubmed: 22339626
Addiction. 2012 Mar;107(3):642-9
pubmed: 21939462
Addiction. 1997 Sep;92(9):1087-97
pubmed: 9374005
J Stud Alcohol. 2000 Mar;61(2):220-4
pubmed: 10757131
JAMA. 2006 May 3;295(17):2003-17
pubmed: 16670409
Alcohol Alcohol. 1993 Mar;28(2):189-97
pubmed: 8517890
Addiction. 2010 Feb;105(2):279-87
pubmed: 20078486
Alcohol Clin Exp Res. 2015 Jun;39(6):1057-63
pubmed: 25903217
JAMA. 2000 May 24-31;283(20):2701-11
pubmed: 10819955
Q J Stud Alcohol. 1972 Mar;33(1):85-90
pubmed: 5059561
Alcohol Clin Exp Res. 2017 Jan;41(1):179-186
pubmed: 28019652
Alcohol Clin Exp Res. 2017 Feb;41(2):414-420
pubmed: 28129451
Addiction. 1995 Sep;90(9):1149-53; discussion 1157-77
pubmed: 7580815
Addiction. 2014 Aug;109(8):1274-84
pubmed: 24661324
Neuropsychopharmacology. 2017 Aug;42(9):1776-1788
pubmed: 28091532
Alcohol. 2005 Jan;35(1):19-26
pubmed: 15922134
Br J Addict. 1990 Jan;85(1):119-23
pubmed: 2310844
Arch Gen Psychiatry. 1974 Apr;30(4):539-47
pubmed: 4131353
Pharmacol Biochem Behav. 2013 Feb;103(4):784-91
pubmed: 23262301
Psychopharmacology (Berl). 2014 Sep;231(17):3609-18
pubmed: 24557088
Am J Drug Alcohol Abuse. 2020;46(1):131-138
pubmed: 31295037
Am J Addict. 2014 Jan-Feb;23(1):96-101
pubmed: 24313247
Annu Rev Pharmacol Toxicol. 2016;56:299-322
pubmed: 26514207
Alcohol Clin Exp Res. 2003 May;27(5):780-6
pubmed: 12766622
Psychopharmacology (Berl). 1997 Jan;129(1):15-22
pubmed: 9122358
Drug Alcohol Depend. 2019 Apr 1;197:228-235
pubmed: 30852375
Pharmacol Biochem Behav. 2015 Nov;138:133-41
pubmed: 26432174
Alcohol Clin Exp Res. 2002 Mar;26(3):326-31
pubmed: 11923584
Addict Biol. 2017 May;22(3):581-615
pubmed: 26833803
J Addict Med. 2016 May-Jun;10(3):166-73
pubmed: 27159341
J Law Med Ethics. 2002 Spring;30(1):73-81
pubmed: 11905272
CNS Neurol Disord Drug Targets. 2010 Mar;9(1):23-32
pubmed: 20201812
Alcohol Clin Exp Res. 2009 Sep;33(9):1508-12
pubmed: 19519721
J Subst Abuse. 1996;8(2):211-25
pubmed: 8880661
Alcohol. 2005 Nov;37(3):135-41
pubmed: 16713501
Alcohol Clin Exp Res. 2016 Jul;40(7):1368-79
pubmed: 27184259
Alcohol Clin Exp Res. 2014 Dec;38(12):3024-32
pubmed: 25581657
Addiction. 2018 Jan;113(1):6-14
pubmed: 28710873
Am J Drug Alcohol Abuse. 2006;32(4):589-97
pubmed: 17127547